Inhibrx Biosciences, Inc. logo INBX - Inhibrx Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 3
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $325.00 DETAILS
HIGH: $325.00
LOW: $325.00
MEDIAN: $325.00
CONSENSUS: $325.00
UPSIDE: 220.77%

Profitability Ratios

Ratio Value
GP Margin -91.0%
EBIT Margin -10386.5%
EBITDA Margin -10195.5%
Operating Margin -10386.5%
Pretax Margin -10773.3%
Cont. Ops Margin -10773.5%
Net Margin -10773.5%
Bottom Line Margin -10773.5%

Liquidity Ratios

Ratio Value
Current Ratio 3.93
Quick Ratio 3.93
Solvency Ratio -0.993
Cash Ratio 3.68

Valuation Ratios

Ratio Value
Price/Earnings
-8.74
Hist. avg: 0.1
Peers avg: 15.9
PEG Ratio 0.08
Forward PEG 0.08
Price/Book 153.07
Price/Sales 941.13
Price/FCF -9.42
Price/Op Cash Flow -9.43

Debt Ratios

Ratio Value
Debt/Assets 0.7306
Debt/Equity 13.3882
Debt/Capital 0.9305
Long-Term Debt/Capital 0.9264
Financial Leverage 18.33

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.01
Operating Cash Flow Ratio -3.840
Operating Cash Flow/Sales -9984.2%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage -9.13
Interest Coverage -11.0713
Short-Term Operating Cash Flow Coverage -55.80
Operating Cash Flow Coverage -1.21
Capital Expenditure Coverage -4186.90
Dividend + Capital Expenditure Coverage -4186.90

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.08
EPS -9.043
Debt/Share 7.6973
Cash/Share 8.02
Book Value/Share 0.52
Tangible BV/Share 0.52
Equity/Share 0.52
Operating Cash Flow/Share -8.381
Capital Expenditure/Share 0.002
FCF/Share -8.383

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 1.037
Price/Fair Value 153.07
Debt/Market Cap 0.0841
Effective Tax Rate -0.0%
Enterprise Value Multiple -9.10